Form 4 holding
EVP, Research and Development
AMGEN INC
- Security class
- Common Stock
- Shares / value
- 30,016
- Estimated value
- $10,561,129
- Report date
- 07 May 2026
- Price
- $351.85
- Ownership
- Direct
James E. Bradner - EVP, Research and Development at AMGEN INC
Issuer-level insider activity
- Role
- EVP, Research and Development
- Issuer ticker
- AMGN on Nasdaq
- Entity type
- Individual
- Source filing history
- Open source filing history
Identity
Names, identifiers, and filing context for this profile.
1 identity field
Source evidence
Original filing metadata and source links for verification.
1 source field
No buys or sells have been reported by James E. Bradner since 14 Aug 2025
Reported holdings for James E. Bradner in AMGEN INC
Form 4 holding
EVP, Research and Development
AMGEN INC
- Security class
- Nqso (Right to Buy)
- Shares / value
- 21,773
- Estimated value
- $6,204,975
- Report date
- 05 May 2026
- Price
- $270.44
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
Transaction history for James E. Bradner in AMGEN INC
| Sym | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares after | Date | Ownership |
|---|
* marks a reported price that did not pass the local price check.